Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases

NCT02448732 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Neovascularization, Pathologic

Interventions

DRUG: ACM-1

Sponsor

Sun Yat-sen University